The GSTM1 null and GSTZ1rs7972 AA genotypes followed a similar trend of doubling the odds of having an MPN, e.g., OR of 2.4 and 2.8, respectively. This evidence concerns the gene GSTM1 and myeloproliferative neoplasm.